日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer

更正:一项加拿大真实世界、多中心、前瞻性观察性研究,评估了接受内分泌治疗±靶向治疗的HR+HER2阴性晚期乳腺癌患者的治疗持续时间、治疗顺序和总生存期

Doyle, Catherine; Lohmann, Ana Elisa; Iqbal, Nayyer; Henning, Jan-Willem; Kulkarni, Swati; Califaretti, Nadia; Hilton, John; Ferrario, Cristiano; Bouganim, Nathaniel; Mates, Mihaela; Guillemette, Stephanie; Leite, Ricardo; Caron, Marc-Andre; Thireau, Francois; Machado, Andres; Chia, Stephen

A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancer

一项加拿大真实世界、多中心、前瞻性观察性研究,旨在评估接受内分泌治疗±靶向治疗的HR+HER2阴性晚期乳腺癌患者的治疗持续时间、治疗顺序和总生存期。

Doyle, Catherine; Lohmann, Ana Elisa; Iqbal, Nayyer; Henning, Jan-Willem; Kulkarni, Swati; Califaretti, Nadia; Hilton, John; Ferrario, Cristiano; Bouganim, Nathaniel; Mates, Mihaela; Guillemette, Stephanie; Leite, Ricardo; Caron, Marc-Andre; Thireau, Francois; Machado, Andres; Chia, Stephen

Adjuvant carboplatin and paclitaxel with "sandwich" method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution

辅助卡铂和紫杉醇化疗联合“三明治”式放疗治疗III期或IV期子宫内膜癌:单中心长期随访研究

Chinnadurai, Anu; Breadner, Daniel; Baloush, Ziad; Lohmann, Ana Elisa; Black, Morgan; D'Souza, David; Welch, Stephen

The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer-A Systematic Review and Meta-Analysis

早期HER2阴性乳腺癌女性患者省略蒽环类化疗——系统评价和荟萃分析

Giffoni de Mello Morais Mata, Danilo; Rush, Mary-Beth; Smith-Uffen, Megan; Younus, Jawaid; Lohmann, Ana Elisa; Trudeau, Maureen; Morgan, Rebecca L

Antibody-Drug Conjugates: A Start of a New Era in Gynecological Cancers

抗体药物偶联物:妇科肿瘤治疗新时代的开始

Fasih, Samir; Welch, Stephen; Lohmann, Ana Elisa

Antibody-Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond-A 2023 Review

乳腺癌抗体药物偶联物:迈向巅峰及未来展望——2023年综述

Xiao, Tian; Ali, Sanji; Mata, Danilo Giffoni M M; Lohmann, Ana Elisa; Blanchette, Phillip S

Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges

癌症患者体成分测量的影像学方法:机遇与挑战

Shah, Urvi A; Ballinger, Tarah J; Bhandari, Rusha; Dieli-Cornwright, Christina M; Guertin, Kristin A; Hibler, Elizabeth A; Kalam, Faiza; Lohmann, Ana Elisa; Ippolito, Joseph E

The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor-Positive Breast Cancer

激素受体阳性乳腺癌辅助治疗试验中无效性分析的徒劳

Lohmann, Ana Elisa; Ennis, Marguerite; Parulekar, Wendy R; Chen, Bingshu E; Tomlinson, George; Goodwin, Pamela J

Obesity and Breast Cancer: Expanding the Hypothesis Space

肥胖与乳腺癌:拓展假设空间

Lohmann, Ana Elisa; Goodwin, Pamela J

The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32

二甲双胍与安慰剂对加拿大癌症试验组性激素的影响 MA.32

Pimentel, Isabel; Chen, Bingshu E; Lohmann, Ana Elisa; Ennis, Marguerite; Ligibel, Jennifer; Shepherd, Lois; Hershman, Dawn L; Whelan, Timothy; Stambolic, Vuk; Mayer, Ingrid; Hobday, Timothy; Lemieux, Julie; Thompson, Alastair; Rastogi, Priya; Gelmon, Karen; Rea, Daniel; Rabaglio, Manuela; Ellard, Susan; Mates, Mihaela; Bedard, Philippe; Pitre, Lacey; Vandenberg, Theodore; Dowling, Ryan J O; Parulekar, Wendy; Goodwin, Pamela J